Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04254185 · ClinicalTrials.gov registry record · NA
Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow
A NA study of Neuropathy Ulnar, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 378
- Enrollment target
- 10
- Study locations
NCT04254185: Recruiting NA study of Neuropathy Ulnar, sponsored by University of Michigan.
NCT04254185 is a NA study of Neuropathy Ulnar that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 378 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04254185, a NA study of Neuropathy Ulnar, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 378 participants
- Enrollment target
- 10
- Study locations
Study Summary
This research is studying two surgical procedures in a large group of people to learn about how well these procedures work as a treatment for ulnar neuropathy at the elbow (UNE). Researchers want to see which surgery is more helpful for people with ulnar neuropathy. This research will determine if one surgery is better than the other to alleviate symptoms.
Primary Outcome
The MHQ is a self-report measure that assesses the function of the hand(s) and/or wrist(s). The MHQ contains six distinct scales assessing overall hand function, activities of daily living, pain, work performance, aesthetics and subject satisfaction with hand function. Scores range from 0-100, 100=no disability). In the pain scale, however, high scores indicate greater pain (0-100, 0=no pain).
Conditions Studied
Interventions
- PROCEDURE Simple decompression
- PROCEDURE Subcutaneous anterior transposition
Study Locations (10)
Maryland
- Johns Hopkins University - Baltimore
- Curtis National Hand Center - Baltimore
North Carolina
- OrthoCarolina Research Institute, Inc. - Charlotte
- Wake Forest University Health Sciences - Winston-Salem
Georgia
- Emory Healthcare - Atlanta
Kentucky
- Norton Healthcare - Louisville
Michigan
- Michigan Medicine - Ann Arbor
Ohio
- Ohio State University - Columbus
Oklahoma
- University of Oklahoma - Oklahoma City
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 378 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2027-10-31 |
| Phase | NA |
What NCT04254185 shows while recruiting
NCT04254185 is an interventional study that assigns participants to a tested intervention. The registered 378 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Neuropathy Ulnar appearing as the primary indexed condition, and to 2 interventions - of which Simple decompression is the first listed.
NCT04254185 lists 10 locations in 8 states (Maryland, North Carolina, Georgia).
Frequently Asked Questions
What is clinical trial NCT04254185 about?
NCT04254185 is a clinical study titled "Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow". This research is studying two surgical procedures in a large group of people to learn about how well these procedures work as a treatment for ulnar neuropathy at the elbow (UNE). Researchers want to see which surgery is more helpful for people with ulnar neuropathy. This research will determine if o...
What is the current status of trial NCT04254185?
This trial is currently recruiting. It is a NA study. The enrollment target is 378 participants. The study started on 2020-02-18. Estimated completion is 2027-10-31.
What conditions does trial NCT04254185 study?
This clinical trial studies the following conditions: Neuropathy Ulnar.
What interventions are being tested in trial NCT04254185?
The interventions under investigation include: Simple decompression (PROCEDURE), Subcutaneous anterior transposition (PROCEDURE).
Who is sponsoring clinical trial NCT04254185?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04254185 being conducted?
This trial has 10 study locations across Georgia, Kentucky, Maryland, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04254185's enrollment target sits among peer trials
378 274th of 2000 higher than 1,727 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06616584 · 378 participants · Phase 2
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- NCT07024784 · 377 participants · Phase 2
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI